문의하기 아이콘
문의하기 텍스트
top 아이콘
about Visual Img about Visual Img
About

Coreline Soft specializes in
developing medical artificial intelligence
solutions, serving healthcare professionals.

Artificial intelligence technology aids
healthcare professionals in achieving more accurate diagnosis
and increased efficiency,

By identifying even minor illnesses,

we aim to improve healthy life expectancy

Coreline Soft is
passionate about the development of
AI imaging solutions.

History

Launched in 2012,
our medical artificial intelligence technology represents Korea and is destined for the world.

2025

  • 06

    Participated in national lung cancer screening initiatives in Norway and Finland

    05

    Successfully secured South Korea’s national lung cancer screening contract for the 9th consecutive year

    Supplied AVIEW Lung Texture to Boehringer Ingelheim Taiwan, a global pharmaceutical company

    Selected as the exclusive AI solution provider for France’s national screening project, IMPULSION

    Entered into a strategic collaboration with Nuance Communications, a U.S.-based AI healthcare company

    Awarded contract for the UK NHS’s Eastern Diagnostic Imaging Network (EDIN)

    Registered AVIEW solutions on UGAP, France’s national public procurement platform

    Signed product supply agreement with Bayer Germany via the Calantic Medical Imaging platform

    Formed strategic distribution partnership with Incepto Medical (France)

    04

    First Korean medical AI company to acquire ISO/IEC 42001 certification

    Signed supply agreement with Micron (Japan-based CRO) for AVIEW COPD

    Formed strategic partnership with SHUIHAI (China) to expand AI applications across Asia

    03

    Received top-grade approval from the Korean MFDS for AI-based lung nodule malignancy prediction software

    Obtained FDA 510(k) clearance for 4 core AVIEW solutions: CAC, LCS, COPD, and Fissure Completeness

    Extended software supply agreement with 3DR Labs for cardiovascular diagnosis support

    02

    AVIEW CAC received FDA 510(k) clearance

    01

    Acquired GDPR and HIPAA international certifications

2024

  • 12

    Received national recognition from the Korean Government for Outstanding Achievement in Commercializing Biomedical Technology

    11

    Received the Presidential Award from the Korea Health Industry Development Institute

    10

    Obtained CE MDR and UKCA certifications

    Launched AVIEW SpineBH, an AI-powered software for vertebral segmentation and spine analysis

    09

    Partnered with University Hospital Cologne and AI platform company Blackford

    08

    Certified for ISO 27001

    06

    Recognized as the provider of the Most Innovative Integrated Medical Devices in Korea

    AVIEW PE was designated an Innovative Medical Device by the Korean MFDS

    05

    Launched AVIEW CHEST, an AI-powered chest CT analysis solution

    04

    AVIEW CAC received FDA 510(k) clearance

    03

    AVIEW HeartX received the iF Design Award in Germany

    AVIEW Aorta designated an Innovative Medical Device by the Korean MFDS

2023

  • 12

    Received the Presidential Award from the Korean Government for excellence in startup innovation

    11

    Signed strategic MOU with Lunit for AI healthcare collaboration

    09

    AVIEW NeuroCAD designated an Innovative Medical Technology under Korea’s nHTA program

    Listed on the KOSDAQ

    06

    AVIEW received medical device license from Health Canada

    Received preliminary listing approval for KOSDAQ from the Korea Exchange (KRX)

    04

    AVIEW received market authorization from ANVISA (Brazil)

    03

    Submitted preliminary KOSDAQ listing application to the Korea Exchange (KRX)

    02

    AVIEW Lung Nodule CAD received FDA 510(k) clearance

    01

    Signed supply agreement with Harbor-UCLA Medical Center for AVIEW CAC, an AI-based imaging analysis software

2022

  • 12

    AVIEW received product registration approval from Singapore’s Health Sciences Authority (HSA)

    Selected as a preferred supplier for South Korea’s AI Voucher Program

    11

    AVIEW RT ACS received FDA 510(k) clearance

    Recognized as an Innovative Medical Device Company by the South Korean Ministry of Health and Welfare

    10

    Received A·A rating in KOSDAQ technology evaluation from authorized South Korean agencies

    AVIEW NeuroCAD selected for the Digital Medical Device Commercialization Support Program

    08

    Selected as one of six global startups for the GE Healthcare Edison Orchestrator Program

    06

    Signed MOU with Weknew for the Medical Twin business

    Formed AI business partnership with Promedius to advance medical imaging solutions

    02

    Certified under the Medical Device Single Audit Program (MDSAP)

2021

  • 12

    Signed supply agreement with ILSP (Italy) to deliver AVIEW AI imaging solution

    03

    Signed supply agreement with HANSE, Germany’s national lung cancer screening project

    AVIEW received product approval from the Taiwan Food and Drug Administration (TFDA)

    Received the Korea Innovation Award for IT Service Excellence

    01

    Signed research collaboration agreement with University Hospitals Leuven (Belgium)

    Signed joint research agreement with Massachusetts General Hospital (MGH), USA

2020

  • 11

    AVIEW NeuroCAD designated as an Innovative Medical Device by Korea’s MFDS

    09

    Established Coreline Europe GmbH in Germany

    Signed development and licensing agreement with GE Healthcare for AI-based brain angiography solution

    08

    Selected as the official AI provider for the “4-In the Lung Run” lung cancer screening project

    07

    Completed Series B funding

    06

    Approved for import and sale in Japan by the Pharmaceuticals and Medical Devices Agency (PMDA)

    05

    AVIEW LCS received FDA 510(k) clearance

    03

    Signed joint development agreement with IDNA for AI medical imaging

2019

  • 12

    AVIEW Modeler received FDA 510(k) clearance

    11

    Signed 5G-based VR technology partnership agreement with KT

    09

    Signed MOU with Naver Business Platform for cloud-based AI infrastructure

    08

    Launched AVIEW LCS, the QA solution for Korea’s national lung cancer screening program

    06

    Received the 1st Chairman’s Award from the Korea SMEs and Startups Agency

2018

  • 12

    Completed Series A funding

    Launched AVIEW, Korea’s first AI-powered lung image analysis solution at RSNA 2018

2017

  • 12

    AVIEW received FDA 510(k) approval

    11

    Received CE certification (EU)

    02

    Awarded contract for the South Korean National Lung Cancer Screening Pilot Project

2016

  • 07

    Korean MFDS approved (Ministry of Food and Drug Safety)

2014

  • 01

    Certified as Venture Enterprise

2012

  • 09

    Establishment of Corelinesoft

Core value

People
of
coreline

Our technology must be outstanding,
so we work with the best colleagues
leading the field of medical artificial intelligence.

  • PEOPLE OF CORELINE Jinkook Kim
    ArrowIcon

    Jinkook Kim

    • CTO, Mevisys Co., Ltd.
    • PhD. Electrical & electronic engineering, KAIST, Korea
    • 20 years in medical solutions

    CEO

    Jinkook Kim

  • PEOPLE OF CORELINE Jaeyoun Yi
    ArrowIcon

    Jaeyoun Yi

    • CTO, Infinitt Healthcare Co., Ltd.
    • Senior developer, Mevisys Co., Ltd.
    • PhD. Electrical & electronic engineering, KAIST, Korea

    CTO

    Jaeyoun Yi

  • PEOPLE OF CORELINE Wooseok Paul Jong
    ArrowIcon

    Wooseok Paul Jong

    • CFO, Creverse Co., Ltd.
    • KB Investment - Private Equity Fund Management
    • Bachelor's Degree in Economics from Seoul National University

    CFO

    Wooseok Paul Jong

  • PEOPLE OF CORELINE Sanghyun Paik
    ArrowIcon

    Sanghyun Paik

    • Prof./M.D./Ph.D., Hangyang Universitty Hospital, Seoul, Korea
    • Prof. Suncheon Univ. Hospital
    • M.D. Ph.D. radiology SoonChunHyang Univ.

    CMO

    Sanghyun Paik

  • PEOPLE OF CORELINE Joonmin Park
    ArrowIcon

    Joonmin Park

    • Prof., Emergency medicine, Ilsan Paik Hospital, & Kangnam Severance Hospital
    • Member of publication, CEEM (Clinical and Experimental Emergency Medicine)
    • MS, Health science, Catholic University, Korea

    CPO

    Joonmin Park

Recruit

Join us on the journey to help shape
the future of medical artificial intelligence for a healthier world

Go to Recruitment

Join us on the journey to help shape
the future of medical artificial intelligence for a healthier world

  • Corline RECRUIT Think

    Think

    Considerate,
    Creative,
    Independent

  • Corline RECRUIT Act

    Act

    Adventurous,
    Diligent,
    Exemplary

  • Corline RECRUIT Communicate

    Communicate

    Communicative,
    Collaborative,
    Selfless

The way

we work

Corline RECRUIT One step ahead

One step ahead.

We constantly move forward, as we recognize
that without action, there can be no change.
We thrive through learning every day.

Corline RECRUIT Always together

Always together

We are respectful and honest with our colleagues
We engage through discussions and support
WE face challenges together with your colleagues,
as true success is collective achievement

Corline RECRUIT We work rationally

We work rationally

We make prompt decisions and conduct efficient meetings
With all the answers at hand, we seek immediate solutions.

Contact

Please leave your inquiry if you have any questions regarding our products, recruitment, investment, or any other matters.

Contact us